DENVER, CO / ACCESSWIRE / March 3, 2016 / American Cannabis Company, Inc. (OTCQB: AMMJ) (the “Company”), a full-service business-to-business consulting solutions provider, and seller of ancillary products to the cannabis industry, today announced it has hired Terry Buffalo as its new Chief Operating Officer.
Terry Buffalo is a seasoned executive in the financial services industry, with extensive experience including managing a hybrid FINRA broker-dealer and Registered Investment Advisor firm. Mr. Buffalo is regarded as an expert in these fields with publications in Financial Advisor Magazine and NAIFA’s Advisor Today, as well as being a featured interview in Boomer Market Advisor. Prior to founding Buffalo Financial Solutions, Buffalo was the Chief Executive Officer of a regional broker dealer for over 10 years, where he took an underperforming firm and revamped the business model from a corporate to an independent structure, with an emphasis on attracting brokers with established clientele. While there, the firm consistently produced net profit of 7%, compared to an industry average among peers that ranged between negative to 1.5%, while helping to expand the firm’s overall assets from $400 million to over $2 billion.
Corey Hollister, the Company’s president and CEO, commented: “The Company is excited to have Mr. Buffalo join our team. Mr. Buffalo’s experience in the securities markets, combined with his operational management experience, provides the company with a skill set it is seeking. Recruiting talent from other professional sectors to complement our team of industry experts is an ongoing component to our human capital strategy, with the goal of provided clients with the highest level of service.”
Separately, the Company announced an update to its February 23, 2016 press release, where it reported receiving notice from the U.S. Patent Office that the Company’s claims for its SatchelTM patent application have been deemed allowable, and the patent application will now move on to issuance. The SatchelTM is a child-resistant vessel that may be used by dispensaries to assemble orders and ensure the proper post sale handling of cannabis per each state’s legislation. Although the Company previously disclosed that The SatchelTM had been awarded an approval from the American Society for Testing and Materials (ASTM),” ASTM does not issue or award approvals. Rather, the testing conducted concerning The SatchelTM was performed in conformity with ASTM standards.
About American Cannabis Company, Inc.:
American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis industry. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. Through our two vertically integrated businesses, American Cannabis Consulting and American Cultivator Company, a group purchasing organization, we support our clients from concept to creation to commercialization to on-going operations.
For more information, please visit: www.americancannabiscompanyinc.com.
Forward Looking Statements
This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate,” “seek,” intend,” “believe,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward- looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.